ConductScience.org, home

Paper3496151

Comparison of multiple anti-CEA immunotoxins active against human adenocarcinoma cells.

Levin LV and 4 others. Cancer Immunol Immunother, 1987. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Comparison of multiple anti-CEA immunotoxins active against human adenocarcinoma cells. Papers, record 3496151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3496151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of multiple anti-CEA immunotoxins active against human adenocarcinoma cells.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2024-04-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Levin LVL V
2Griffin TWT W
3Childs LRL R
4Davis SS
5Haagensen DE JrD E

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Carcinoembryonic AntigenMajor topic
Colonic NeoplasmsMajor topic
ImmunotoxinsMajor topic
RicinMajor topic
Antibodies, Monoclonal
Cell Line
Cell Survival
Dose-Response Relationship, Immunologic
Humans
Neoplasm Proteins

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA 29160NCI NIH HHSUnited StatesR01CA029160PubMed and NIHNIH RePORTER
R01 CA 39748NCI NIH HHSUnited StatesR01CA039748PubMed and NIHNIH RePORTER
SO7RRO5712NCRR NIH HHSUnited StatesPubMedPubMed
S07RR005712NIHNIH RePORTER

Download CSV of grants

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13543060Capture and detection of carcinoembryonic antigen on antibody coated beads used in enzyme immunoassay.J Immunoassay1986https://conductscience.org/library/papers/3543060PubMed
26777083Evaluation of baboon antiserum to carcinoembryonic antigen.Clin Chem1980https://conductscience.org/library/papers/6777083PubMed
36255389Observations on the synthesis of carcinoembryonic antigen by an established human colonic carcinoma cell line.Oncology1980https://conductscience.org/library/papers/6255389PubMed
46655236The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method.J Immunol Methods1983https://conductscience.org/library/papers/6655236PubMed
54842259Proceedings: Interrelationship of carcinoembryonic antigen and colon carcinoma antigen-3.Cancer Res1974https://conductscience.org/library/papers/4842259PubMed
67042541Monoclonal antibody-ricin or ricin A chain hybrids: kinetic analysis of cell killing for tumor therapy.Immunol Rev1982https://conductscience.org/library/papers/7042541PubMed
76120167Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution.J Biol Chem1982https://conductscience.org/library/papers/6120167PubMed
86967725The kinetics of antibody binding to membrane antigens in solution and at the cell surface.Biochem J1980https://conductscience.org/library/papers/6967725PubMed
96218613Immunotoxins: a new approach to cancer therapy.Science1983https://conductscience.org/library/papers/6218613PubMed
105636556Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro.J Exp Med1968https://conductscience.org/library/papers/5636556PubMed
116948605Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.Cancer Res1982https://conductscience.org/library/papers/6948605PubMed
126306663Enhancement of toxicity of antitransferrin receptor antibody-Pseudomonas exotoxin conjugates by adenovirus.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6306663PubMed
136254650Factors affecting the expression of carcinoembryonic antigen at the surface of cultured human colon carcinoma cells.Cancer Res1980https://conductscience.org/library/papers/6254650PubMed
146956757Selective cytotoxicity of a ricin A-chain-anti-carcinoembryonic antigen antibody conjugate for a human colon adenocarcinoma cell line.J Natl Cancer Inst1982https://conductscience.org/library/papers/6956757PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
35338415Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer Efficacy.AAPS J2022https://conductscience.org/library/papers/35338415PubMed
27721658Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins.Biomark Cancer2016https://conductscience.org/library/papers/27721658PubMed
25341935Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.Curr Pharm Des2014https://conductscience.org/library/papers/25341935PubMed
21138845Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.J Biol Chem2011https://conductscience.org/library/papers/21138845PubMed
8306371Internalization of an intact doxorubicin immunoconjugate.Cancer Immunol Immunother1994https://conductscience.org/library/papers/8306371PubMed
3490911Non-human primate (baboon) anti-carcinoembryonic antigen antibody infusion in patients with metastatic adenocarcinoma. A phase I study.Cancer Immunol Immunother1986https://conductscience.org/library/papers/3490911PubMed
2598192Selective killing of carcinoembryonic-antigen (CEA)-producing cells in vitro by the immunoconjugate cytorhodin-S and CEA-reactive cytorhodin-S antibody CA208.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2598192PubMed
2193879Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.Indian J Pediatr1990https://conductscience.org/library/papers/2193879PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3496151

GET https://conductscience.org/api/papers/v1/3496151/authors